Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
CRSP
CRSP
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest CRSP ETF News Today | Earnings, Events & Price Alerts
CRSP News
CRISPR Therapeutics: Potential and Challenges in Gene Editing
9h ago
Fool
CRISPR Therapeutics Faces Significant Challenges Amid Slow Rollout
9h ago
NASDAQ.COM
Cathie Wood's Latest Investment Moves in Ark Innovation ETF
1d ago
Fool
CRISPR Therapeutics Shares Surge on Strong Earnings and Pipeline Growth
4d ago
Benzinga
Crispr Therapeutics Rises 5% Amid Acquisition Speculation
4d ago
seekingalpha
FDA Unveils New Guidance to Accelerate Rare Disease Therapy Approvals
Feb 23 2026
seekingalpha
CRISPR Therapeutics: Promising Pipeline and Risks Ahead
Feb 20 2026
Fool
Promising Future for CRISPR Therapeutics
Feb 20 2026
NASDAQ.COM
CRISPR Therapeutics Shows Long-Term Investment Potential
Feb 20 2026
Fool
Biotech Stocks with High Growth Potential
Feb 20 2026
Fool
CRISPR Therapeutics Sees Stock Increase Following Earnings Report Amid Promising Pipeline Developments
Feb 19 2026
Marketbeat
Analysis of CRISPR Therapeutics' Future Prospects
Feb 18 2026
Fool
CRISPR Therapeutics: A Biotech Stock Poised for Growth
Feb 13 2026
Fool
CRISPR Therapeutics Shows Growth Potential
Feb 13 2026
NASDAQ.COM
CRISPR Therapeutics Stock Rises Despite Poor Q4 Earnings
Feb 13 2026
Fool
Casgevy Therapy Revenue Shows Significant Growth
Feb 13 2026
Benzinga
Show More News
